Guidance| Page 4 of 4 | The British Society of Gastroenterology

Guidance

NICE Guidance on vedolizumab for treating moderately to severely active ulcerative colitis

First published on 05 Jun 2015

June 2015 Vedolizumab (Entyvio) is recommended by NICE as a possible treatment for adults with moderate to severe ulcerative colitis. People should be able to have the treatment until it stops working or surgery is needed. Their condition should be […]

Guidance

Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy

First published on 25 Feb 2015

February 2015 Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262) Infliximab (also known as Remicade, Inflectra or Remsima), adalimumab (Humira) and golimumab (Simponi) […]

Guidance

The practical management of the gastrointestinal symptoms of pelvic radiation disease

First published on 01 Jul 2014

Misc authors, July 2014 A new report from Jervoise Andreyev and his team at the Marsden was published as an open access article in Frontline Gastroenterology and can be found via the link below. Macmillan funded the design and print […]

Guidance

ERCP – The Way Forward, A Standards Framework

First published on 01 Jun 2014

ERCP – The Way Forward, A Standards Framework Mark Wilkinson, (BSG Endoscopy, working party convenor and chairman) et al. June 2014 Executive Summary: To improve the quality and availability of ERCP in the UK, a working party was set up incorporating […]

Guidance

NICE Diagnostics Guidance: Faecal Calprotectin Diagnostic Tests for IBD

First published on 01 Oct 2013

Faecal calprotectin testing is recommended as an option to support clinicians with the differential diagnosis of inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS) in adults with recent onset lower gastrointestinal symptoms for whom specialist assessment is being considered, […]

Guidance

Faecal calprotectin testing: Putting the NICE guidance into practice

First published on 01 Oct 2013

NICE has released an adoption resource, which aims to support people using the NICE guidance – Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel. This resource has been designed for both clinical and non-clinical staff who are planning to […]

Guidance

Guidance on the indications for diagnostic upper GI endoscopy, flexible sigmoidoscopy and colonoscopy

First published on 04 Jan 2013

Adam Harris Chair, BSG Clinical Services and Standards Committee (CSSC) – April 2013 In 2011 the Independent Practice Committee of the BSG was asked to provide approved guidance on the indications for diagnostic endoscopy. There was none although it was […]

Guidance

Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer

First published on 04 Nov 2011

The number of patients with chronic gastrointestinal (GI) symptoms after cancer therapies which have a moderate or severe impact on quality of life is similar to the number diagnosed with inflammatory bowel disease annually. However, in contrast to patients with […]